Home » Topics » BioWorld Science

BioWorld Science
RSS

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Creative BioMolecules/Stryker dental and periodontal collaboration

Nov. 26, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Gel for dermal augmentation introduced in Europe

Nov. 26, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Nippon Shinyaku R&D pipeline in review

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...